PRKDC and neoplasm: Overcoming these hurdles requires a multipronged approach: deeper mechanistic studies of DNA-PKcs regulation using systems biology methods, longitudinal analyses to identify optimal treatment windows, and rational combination strategies (e.g., with radiotherapy or immunotherapy) to enhance tumor specificity and overcome microenvironmental resistance.